Notable
TEAM PC · Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate Cancer
Primary completion pushed from Jan 31, 2026 to Dec 31, 2027
Also in this update: Trial sites expanded: 12 → 19 locations; Study completion pushed from Oct 31, 2027 to Feb 28, 2029
Fundacion OncosurPhase 2 NCT06582628 Registry history of NCT06582628 on ClinicalTrials.gov (opens the registry)